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Summary
Porous biomaterials composed of highly purified collagen and
solubilised elastin were prepared by freezing and lyophilisation
and studied by subcutaneous implantation in young Sprague
Dawley rats. The scaffolds, containing depots of soluble elastin,
showed no calcification in this sensitive calcification model, in
contrast to scaffolds containing insoluble elastin fibres. Scaffolds
induced the formation of blood vessels and promoted elastic fibre
synthesis as was shown with specific antibodies.
Introduction
Elastin is the prime protein in tissues that display elasticity of
e.g. lung, aorta, and skin. Upon injury, elastic fibres are not
readily replaced which causes a delay in tissue regeneration.
Incorporation of solubilised elastin (obtained from insoluble
elastin fibres by hydrolysis) into biomaterials may improve
tissue regeneration, since solubilised elastin is able to promote
fibroblast proliferation as well as elastin synthesis [1–3].
Experimental methods
Elastin fibres were hydrolysed by means of oxalic acid [4].
Three different scaffolds were prepared composed of: collagen
(COL) [5,6], collagen+elastin fibres (COL–ELfibre) [7,8], and
collagen+solubilised elastin (COL–ELsol). All scaffolds were
chemically crosslinked and morphologically and biochemically
characterised. Scaffolds were subcutaneously implanted in
3 weeks old Sprague Dawley rats, and retrieved after 3, 7,
and 21 days. Paraffin sections of explants were stained with
haematoxylin–eosin; elastin and collagen were stained accord-
ing to Elastin Van Gieson; calcium deposits were visualized by
Von Kossa staining. Cryo-sections were stained for type IV
collagen, rat elastin and the elastin fibre-associated molecule
fibrillin using specific antibodies (immunohistochemistry).
Results and discussion
Porous biomaterials composed of collagen and solubilised
elastin could be prepared by freezing and lyophilising.
Solubilised elastin was associated with the collagen fibrils of
the scaffolds. Over time, solubilised elastin was released from
the COL–ELsol scaffold as indicated by reduced Elastin-Van
Gieson staining. However, at day 21 after implantation,
substantial staining was still present in the scaffolds, indicating
a slow release mechanism.
Blood vessels were most abundant in COL–ELsol scaffolds,
both at the periphery and within the scaffold as analysed by type
IV collagen staining. These scaffolds also contained more large
blood vessels than COL–ELfibre and COL. In COL–ELfibre,
vascularisation was considerably less. In COL, blood vessels
were found only at the periphery of the scaffolds.
At day 21, COL–ELsol scaffolds showed most new rat
elastin, not only in blood vessels, but also as thin elastic fibres
within the scaffold. In COL–ELfibre scaffolds, new elastin was
found mainly in blood vessels present in the capsule around the
implant and small amounts of thin elastic fibres were
sporadically found at the periphery of the scaffolds.
In COL scaffolds, rat elastin was present only in blood
vessels in the capsule. In blood vessels, rat elastin co-localised
with fibrillin-1 and fibrillin-2 staining, but only fibrillin-1
staining co-localised with the thin elastic fibres.
COL–ELsol scaffolds did not calcify during the time course
of the experiment in contrast to COL–ELfibre scaffolds (Fig. 1).
In COL–ELfibre scaffolds, elastin fibres calcified from day 7
onwards, whereas the collagen fibrils did not. Scaffolds
composed of only collagen did not calcify.
Conclusion
COL–ELsol scaffolds provide a non-calcifying release
vehicle for solubilised elastin that stimulate angiogenesis and
Fig. 1. Light microscopical evaluation of the calcification of crosslinked
scaffolds, 21 days after implantation in young Sprague Dawley rats for (A)
COL–ELsol and (B) COL–ELfibre scaffolds. Calcium deposits have an intense
black colour due to Von Kossa staining. In COL–ELfibre, deposits were only
associated with elastin fibres.
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elastic fibre formation and have great potential for soft tissue
engineering.
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Summary
In this study, the preliminary results on the mechanical and
rheological properties of a new delivery system based on
Pluronic and alginate are reported. The system described is
specifically designed to carry into the blood vessel a new
antiproliferative molecule representing an original approach to
in-stent restenosis therapeutic treatment.
Introduction
Percutaneous transluminal angioplasty (PTA) has been used
in the past to treat artery occlusion (stenosis) due to
atherosclerotic plaques, mechanically removing the endo-
vascular plaque. Because of the frequent re-occlusion (rest-
enosis) of the treated vessel [1], bare-metal stents nowadays are
usually placed in the artery lumen at the site of stenosis,
significantly improving the clinical outcome of treated patients.
Indeed, the frequent induction of the exuberant proliferation of
coronary smooth muscle cells (CSMCs), determines the re-
occlusion of the treated vessel (in-stent restenosis) [2,3,4] (Fig. 1).
This problem has been partially overcome by the use of drug-
eluting stents (DES) which are able to deliver in situ
antiproliferative drugs. Recently we focused our attention on a
novel kind of antiproliferative molecules termed small interfering
RNAs (siRNAs) [5]. These molecules need to be complexed with
liposomes to cross cellular membranes efficiently in order to exert
their therapeutic effect. To carry and deliver such liposomes
locally, the gelling matrix made up by Pluronic F127 (PF127) and
alginate has been proposed as a suitable endo-arterial delivery
system. In fact, PF127 and alginate, separately, are able to form
reverse thermoresponsive hydrogels and temperature insensitive
ionotropic gels respectively. The innovative therapeutic procedure
Fig. 1. Schematic representation of in-stent restenosis.
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